Sulfuretin

Sulfuretin

SCHEMBL8346701

O=C1/C(=C\c2ccc(O)c(O)c2)Oc2cc(O)ccc21

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 8/20 1.00
KMT2A Q03164 8/20 1.00
RECQL P46063 4/20 1.00
STK17B O94768 3/20 1.00
MAOA P21397 3/20 1.00
KDM4E B2RXH2 2/20 1.00
NPC1 O15118 2/20 1.00
GAA P10253 2/20 1.00
MAPT P10636 2/20 1.00
AURKA O14965 2/20 1.00
GSK3B P49841 2/20 1.00
CDK5 Q00535 2/20 1.00
CDK5R1 Q15078 2/20 1.00
PSMD14 O00487 1/20 1.00
DAPK3 O43293 1/20 1.00
JAK2 O60674 1/20 1.00
ALPL P05186 1/20 1.00
ALPI P09923 1/20 1.00
ALPG P10696 1/20 1.00
CDK4 P11802 1/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sulfuretin SCHEMBL30214394 1.00 MEN1 (1.00) MEN1KMT2ARECQLSTK17BMAOA
Sulfuretin SCHEMBL30214408 1.00 MEN1 (1.00) MEN1KMT2ARECQLSTK17BMAOA
Sulfuretin SCHEMBL634007 1.00 MEN1 (1.00) MEN1KMT2ARECQLSTK17BMAOA
Sulfuretin SCHEMBL634006 1.00 MEN1 (1.00) MEN1KMT2ARECQLSTK17BMAOA
Sulfuretin SCHEMBL29545005 1.00 MEN1 (1.00) MEN1KMT2ARECQLSTK17BMAOA
SCHEMBL30337058 0.89 STK17B (1.00) MEN1KMT2ARECQLSTK17BMAOA
SCHEMBL5707753 0.88 TYR (1.00) MEN1KMT2ARECQLSTK17BMAOA
SCHEMBL29435856 0.88 TYR (1.00) MEN1KMT2ARECQLSTK17BMAOA
SCHEMBL30214422 0.88 TYR (1.00) MEN1KMT2ARECQLSTK17BMAOA
SCHEMBL6964950 0.88 MEN1 (0.78) MEN1KMT2ARECQLSTK17BMAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7524836-B2 Nitrooxyderivative steroidal compounds NICOX S.A. (FR) 2009-04-28 US disclosed
US-7378412-B2 Pharmaceutical compounds NICOX S.A. (FR) 2008-05-27 US disclosed
US-7378412-B2 Pharmaceutical compounds NICOX S.A. (FR) 2008-05-27 US disclosed
US-20070142342-A1 Pharmaceutical compounds NICOX S.A. 2007-06-21 US disclosed
US-20070142342-A1 Pharmaceutical compounds NICOX S.A. 2007-06-21 US disclosed
US-7186708-B2 Steroidal compounds NICOX S.A. (FR) 2007-03-06 US disclosed
US-7186708-B2 Steroidal compounds NICOX S.A. (FR) 2007-03-06 US disclosed
US-20070010458-A1 Drugs for the arthritis treatment NICOX S.A. (FR) 2007-01-11 US disclosed
US-20070010458-A1 Drugs for the arthritis treatment NICOX S.A. (FR) 2007-01-11 US disclosed
WO-2003095471-A2 DEOXYCHOLIC ACID DERIVATIVES FOR THE TREATMENT OF ACUTE DYSFUNCTIONS OF PORTAL AND HEPATIC VENOUS CIRCULATION NICOX S.A. (IT) 2003-11-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070142342-A1 Pharmaceutical compounds CYP11B2, CYP11B1, CYP2S1 MEN1 533/4885KMT2A 4240/4885RECQL 488/4885
US-20070010458-A1 Drugs for the arthritis treatment PTGS1, ADORA2B, PTGS2 MEN1 3932/4885KMT2A 4003/4885RECQL 901/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.